The Nation - News from Sept. 25, 1985
- Share via
Tests of genetic therapy that may offer the first treatment for certain hereditary diseases could begin within months, now that a federal advisory group has approved guidelines for the experimental work, specialists say. A National Institutes of Health advisory committee has completed work on guidelines for human tests of gene therapy, a new approach to getting at the causes of hereditary diseases and modifying them. The Recombinant DNA Advisory Committee unanimously adopted a set of points that should be considered by researchers coming to the panel with proposals.
More to Read
Sign up for Essential California
The most important California stories and recommendations in your inbox every morning.
You may occasionally receive promotional content from the Los Angeles Times.